KIRSCH ARTHUR S bought AVIR
June 18, 2026 · Form 4 insider transaction
KIRSCH ARTHUR S bought 37,700 shares of Atea Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
37,700
Price
$0.00
Total value
N/A
InsiderKIRSCH ARTHUR S
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 18, 2026
Filing dateJune 23, 2026
Shares owned after37,700
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date.